MITIGARE (Hikma Americas, Inc.)
Welcome to the PulseAid listing for the MITIGARE drug offered from Hikma Americas, Inc.. This Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Interactions [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hikma Americas, Inc. |
| NON-PROPRIETARY NAME: | Colchicine |
| SUBSTANCE NAME: | COLCHICINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Interactions [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-10-01 |
| END MARKETING DATE: | 0000-00-00 |
MITIGARE HUMAN PRESCRIPTION DRUG Details:
| Item Description | MITIGARE from Hikma Americas, Inc. |
| LABELER NAME: | Hikma Americas, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.6(mg/1) |
| START MARKETING DATE: | 2014-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59467-318_00ac0296-f6ef-4657-bd3b-c1c405ea4015 |
| PRODUCT NDC: | 59467-318 |
| APPLICATION NUMBER: | NDA204820 |
Other COLCHICINE Pharmaceutical Manufacturers / Labelers:
